Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

BNTX

BioNTech SE ADR

Dec 12 • 04:00PM ET

120.69

Dollar change +1.35
Percentage change 1.13	%

Healthcare • Biotechnology • Germany • NASD

Peers: MRNA PFE NVAX AZN JNJ GSK BMY GILD LLY SNY

| Held by: IBB FBT FNDF BBH SPDW IDNA TCAF QQQJ GNOM ONEQ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.15	Insider Own	0.13%	Shs Outstand	239.74M	Perf Week	1.56%
Market Cap	28.93B	Forward P/E	-	EPS next Y	-3.54	Insider Trans	0.00%	Shs Float	239.44M	Perf Month	13.52%
Income	-501.56M	PEG	-	EPS next Q	0.50	Inst Own	19.46%	Short Float	0.99%	Perf Quarter	-2.20%
Sales	3.30B	P/S	8.77	EPS this Y	-184.64%	Inst Trans	4.04%	Short Ratio	2.18	Perf Half Y	25.72%
Book/sh	88.98	P/B	1.36	EPS next Y	-3.95%	ROA	-2.07%	Short Interest	2.36M	Perf Year	22.34%
Cash/sh	77.78	P/C	1.55	EPS next 5Y	-	ROE	-2.37%	52W Range	76.53 - 131.49	Perf YTD	14.35%
Dividend Est.	-	P/FCF	19.57	EPS past 5Y	-	ROI	-2.33%	52W High	-8.21%	Beta	0.16
Dividend TTM	-	Quick Ratio	7.21	Sales past 5Y	843.27%	Gross Margin	84.31%	52W Low	57.70%	ATR (14)	5.10
Dividend Ex-Date	Jun 02, 2022	Current Ratio	7.33	EPS Y/Y TTM	-118.03%	Oper. Margin	-8.08%	RSI (14)	57.89	Volatility	4.54% 5.05%
Employees	3082	Debt/Eq	0.01	Sales Y/Y TTM	-52.11%	Profit Margin	-15.20%	Recom	1.50	Target Price	138.99
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	22.07%	Payout	0.00%	Rel Volume	0.61	Prev Close	119.34
Sales Surprise	141.90%	EPS Surprise	152.75%	Sales Q/Q	40.41%	Earnings	Nov 04 BMO	Avg Volume	1.09M	Price	120.69
SMA20	5.91%	SMA50	5.97%	SMA200	23.71%	Trades		Volume	660,594	Change	1.13%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-11-24	Initiated	Wells Fargo	Overweight	$170
Dec-02-24	Reiterated	BMO Capital Markets	Outperform
Nov-19-24	Upgrade	Evercore ISI	In-line → Outperform	$110 → $125
Nov-19-24	Initiated	Berenberg	Buy	$130
Nov-08-24	Upgrade	Goldman	Neutral → Buy	$90 → $137
Sep-24-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$93 → $145
Sep-17-24	Upgrade	Jefferies	Hold → Buy	$96 → $150
Sep-16-24	Upgrade	JP Morgan	Underweight → Neutral	$91 → $125
Aug-07-24	Upgrade	Deutsche Bank	Hold → Buy	$95
Aug-02-24	Upgrade	HSBC Securities	Hold → Buy
May-14-24	Initiated	Evercore ISI	In-line	$100
Feb-23-24	Initiated	BMO Capital Markets	Outperform	$127
Jan-05-24	Initiated	Oppenheimer	Perform
Dec-01-23	Downgrade	JP Morgan	Neutral → Underweight	$106 → $99
Oct-16-23	Downgrade	HSBC Securities	Buy → Hold	$124 → $111
Jul-14-23	Initiated	HSBC Securities	Buy	$124
May-17-23	Upgrade	Redburn	Neutral → Buy	$165 → $170
Dec-15-22	Upgrade	BofA Securities	Neutral → Buy	$239
Aug-17-22	Initiated	Cowen	Market Perform	$177
Jul-13-22	Upgrade	SVB Leerink	Mkt Perform → Outperform

Show Previous Ratings

Dec-11-24 05:50AM	2 Healthcare Stocks to Buy Hand Over Fist and 1 to Avoid (Motley Fool)
Dec-09-24 05:50AM	2 No-Brainer Stocks to Buy Before the End of 2024 (Motley Fool)
Dec-06-24 01:14PM	Why Is BioNTech Stock Trading Higher On Friday? (Benzinga)
Dec-04-24 05:45AM	5 Top Stocks to Buy in December (Motley Fool)
Dec-02-24 02:51PM	Why Is BioNTech SE (BNTX) Among the Best High Growth Healthcare Stocks to Invest In Now? (Insider Monkey)
07:50AM	Loading…
07:50AM	Analyst Report: BioNTech SE (Morningstar Research)
Nov-27-24 07:01AM	BioNTech price target lowered to $122 from $124 at JPMorgan (TipRanks)
Nov-25-24 06:48PM	Analyst Report: BioNTech SE (Morningstar Research) +6.74%
Nov-20-24 05:20AM	BioNTech upgraded to Outperform from In Line at Evercore ISI (TipRanks)
05:00AM	Moderna initiated with a Hold at Berenberg (TipRanks)
04:55AM	BioNTech initiated with a Buy at Berenberg (TipRanks)
Nov-19-24 06:15PM	Is BioNTech SE (BNTX) the Best German Stock to Buy Now? (Insider Monkey)
11:57AM	BioNTech Stock Has Been Hit Hard Since RFK Jr.s Nomination. Why This Analyst Upgraded It. (Barrons.com)
Nov-18-24 12:48AM	Analyst Report: BioNTech SE (Morningstar Research)
Nov-15-24 04:19PM	Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS (Investor's Business Daily)
12:04PM	Loading…
12:04PM	Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS (Investor's Business Daily)
11:15AM	Trumps RFK Jr. Pick Weighs on Vaccine Makers (The Wall Street Journal)
10:46AM	Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick (Yahoo Finance Video)
08:14AM	BioNTech SEs Strategic Growth in Oncology and mRNA (TipRanks)
Nov-14-24 04:32AM	BioNTech signs agreement to acquire Biotheus (Pharmaceutical Technology) -7.10%
Nov-13-24 02:58PM	BioNTech to Acquire Biotheus for $800 Million to Expand Oncology Portfolio (GuruFocus.com)
01:08PM	BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition (Benzinga)
06:45AM	BioNTech to Acquire Biotheus to Boost Oncology Strategy (GlobeNewswire)
01:45AM	BioNTech to buy Biotheus, gaining control of cancer bispecific (BioPharma Dive)
Nov-09-24 02:12PM	BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential (Benzinga)
Nov-06-24 01:15PM	Vaccine Stocks Drop on Worries About an RFK Jr. Role (The Wall Street Journal)
Nov-05-24 07:17AM	BioNTechs Q3 2024: Strong Revenue and Oncology Progress (TipRanks)
07:17AM	BioNTech SE Reports Strong Revenue Growth Amid Rising R&D Costs (TipRanks)
03:28AM	Q3 2024 BioNTech SE Earnings Call (Thomson Reuters StreetEvents)
02:02AM	BioNTech SE (BNTX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Advancements ... (GuruFocus.com)
12:10AM	Loading…
12:10AM	Analyst Report: BioNTech SE (Morningstar Research)
Nov-04-24 06:39PM	Analyst Report: BioNTech SE (Morningstar Research)
04:04PM	BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat (Investor's Business Daily)
02:15PM	BioNTech Se (BNTX) Q3 2024 Earnings Call Transcript (Motley Fool)
09:41AM	BioNTech Variant-adapted COVID-19 Vaccines Do Well In Q3 (Benzinga)
08:56AM	BioNTech Jumps On Surprise Profit, Wide Sales Beat; But Lowers Outlook (Investor's Business Daily)
07:07AM	BioNTech Q3 Net Profit Rises; Backs FY24 Revenue Outlook Range, But At The Low End (RTT News)
06:45AM	BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update (GlobeNewswire)
Oct-31-24 07:45AM	BioNTech to Host Innovation Series R&D Day on November 14, 2024 (GlobeNewswire)
Oct-29-24 03:49PM	Pfizer CEO: The activist investors are 'too late' (Yahoo Finance)
Oct-23-24 04:00AM	A slow start for self-amplifying mRNA vaccines (Pharmaceutical Technology)
Oct-21-24 03:44PM	Analyst Report: BioNTech SE (Morningstar Research)
12:51PM	FDA Presses Clinical Hold Button For BioNTech's Partner Late-Stage Trial Of Investigational Lung Cancer Treatment (Benzinga)
07:40AM	FDA clamps partial hold on Phase III trial of BioNTech & OncoC4s NSCLC therapy (Clinical Trials Arena)
06:45AM	BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024 (GlobeNewswire)
Oct-18-24 04:14PM	mRNA licensing agreements surge 800% amid GSK lawsuits (Pharmaceutical Technology)
10:25AM	BioNTech shares slip as FDA places partial clinical hold on lung cancer study (Investing.com)
Oct-16-24 06:59AM	GSK claims Moderna infringed mRNA vaccine patents (BioPharma Dive)
Oct-14-24 11:13PM	'Where we are today in biology AI is similar to GPT in 2020': An interview with the CEO of Africa's biggest AI startup (TechCrunch)
Oct-08-24 05:50AM	Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents (Reuters)
Oct-07-24 01:00PM	Starboard Value takes $1 billion stake in Pfizer: Reports (Yahoo Finance)
Oct-01-24 06:00AM	BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day (GlobeNewswire)
Sep-25-24 11:13AM	As GSK discontinues HSV vaccine, opportunities remain for Moderna and BioNTech (Clinical Trials Arena)
Sep-20-24 08:11AM	Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union (Business Wire)
Sep-19-24 12:02PM	BioNTech Is More Than a Covid-19 Stock. Its Having a Great September. (Barrons.com)
05:12AM	Mpox: Three ongoing vaccine trials to watch (Clinical Trials Arena)
Sep-17-24 04:09PM	How BioNTech, Up 26% Over Four Days, Is Riding Summit's Coattails To A Recovery (Investor's Business Daily) -7.29%
06:45AM	BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024 (GlobeNewswire)
04:24AM	Here's Why Everyone's Talking About Summit Therapeutics (Motley Fool)
Sep-13-24 06:41PM	Analyst Report: BioNTech SE (Morningstar Research) +17.52%
09:34AM	BioNTech (BNTX) Stock Jumps 5.8%: Will It Continue to Soar? (Zacks)
06:12AM	ESMO 2024: Modernas mRNA solid tumour vaccine shows early promise (Clinical Trials Arena)
Sep-05-24 07:15AM	BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024 (GlobeNewswire)
Sep-04-24 09:15AM	New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth (GlobeNewswire)
08:30AM	Tempus Announces Real World Data Collaboration with BioNTech (Business Wire)
Aug-26-24 06:52AM	BioNTech initiates global trials of mRNA-based lung cancer vaccine (Clinical Trials Arena)
Aug-23-24 02:01PM	The FDA Approved New Covid Vaccines. Should You Get One? (The Wall Street Journal)
Aug-22-24 02:33PM	FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot (Benzinga)
02:15PM	Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine (Business Wire)
01:44PM	The FDA Approved a New Covid Vaccine. Should You Get It? (The Wall Street Journal)
Aug-21-24 12:12AM	Pfizer forecasts $26bn of Covid-19 vaccine revenue after first-quarter success (Pharmaceutical Technology)
Aug-20-24 05:52AM	FDA greenlights BioNTech/Medilinks cancer trial at lower dose after deaths (Clinical Trials Arena)
Aug-19-24 09:39AM	FDA Allows Resumption Of BioNTech/MediLink Therapeutics Partnered Phase 1 Study For Cancer Drug With Lower Dose (Benzinga) +5.56%
08:05AM	FDA lifts partial hold on study of BioNTech-partnered ADC (BioPharma Dive)
04:07AM	Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell? (Motley Fool)
Aug-16-24 11:12PM	Pfizer and BioNTechs Covid-19/flu combination vaccine falters in Phase III readout (Clinical Trials Arena)
04:21PM	Pfizer, BioNTech hit roadblock in COVID-flu vaccine trial (Yahoo Finance Video)
04:08PM	Pfizer Slides Toward Sell Zone After BioNTech-Tied Covid/Flu Shot Misses Its Mark (Investor's Business Daily)
01:29PM	Pfizer, BioNTech Combination Flu and COVID-19 Shot Misses 1 of 2 Endpoints (Investopedia)
10:21AM	Pfizers Stumble on Flu and Covid Shot Is a Plus for Moderna (Barrons.com)
08:20AM	Pfizer, BioNTech stumble in effort to develop combination flu, COVID shot (BioPharma Dive)
06:45AM	Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of Age (GlobeNewswire)
Aug-13-24 02:43PM	Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows (Benzinga)
Aug-08-24 06:40AM	3 Biotech Stocks With Promising Drug Pipelines: August 2024 (InvestorPlace)
Aug-05-24 02:30PM	BioNTech Se (BNTX) Q2 2024 Earnings Call Transcript (Motley Fool)
01:24PM	Analyst Report: BioNTech SE (Morningstar Research)
11:53AM	BioNTech exits PD-L1 development with Genmab as Q2 revenues drop (Pharmaceutical Technology)
10:28AM	BioNTech's Loss Quadruples as COVID-19 Vaccine Demand Falls (Investopedia)
07:59AM	BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products (Benzinga)
06:02AM	BioNTech counts on shift to cancer drugs after second quarter losses quadruple (Reuters)
05:59AM	BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update (GlobeNewswire)
Jul-30-24 06:52AM	BioNTech's cancer drug meets primary endpoint in Phase 2 trial (Reuters)
06:45AM	BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patients with Advanced Melanoma (GlobeNewswire)
Jul-24-24 06:33AM	Triastek and BioNTech to develop 3D-printed RNA therapeutics (Pharmaceutical Technology)
Jul-22-24 06:45AM	BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024 (GlobeNewswire)
Jul-02-24 08:00AM	3 Nasdaq Stocks to Sell in July Before They Crash & Burn (InvestorPlace)
Jul-01-24 11:00PM	Surprise! 3 Stocks That Are Outperforming Nvidia in 2024. (InvestorPlace)
12:34PM	Lab to jab in 100 days: manufacturing flexibility for future rapid responses (Pharmaceutical Technology)
12:19PM	3 Dividend Stocks Yielding Over 3% With Multi-Decade Payout Growth Streaks (InvestorPlace)
Jun-28-24 04:32AM	CHMP recommends authorisation for Pfizer-BioNTechs Covid-19 vaccine (Pharmaceutical Technology)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
ATHOS KG	10% Owner	Dec 11 '24	Proposed Sale	116.85	22,450	2,623,283	Dec 11 05:25 PM
ATHOS KG	10% Owner	Dec 09 '24	Proposed Sale	121.72	53,716	6,538,312	Dec 09 06:35 PM
ATHOS KG	10% Owner	Dec 06 '24	Proposed Sale	118.84	13,104	1,557,279	Dec 06 05:57 PM
ATHOS KG	10% Owner	Nov 27 '24	Proposed Sale	118.54	44,374	5,260,094	Nov 27 05:50 PM
ATHOS KG	10% Owner	Nov 26 '24	Proposed Sale	120.76	10,000	1,207,600	Nov 26 06:37 PM
ATHOS KG	10% Owner	Nov 25 '24	Proposed Sale	113.13	75,000	8,484,750	Nov 25 05:06 PM
Jeggle Helmut Wolfgang	Director	Nov 15 '24	Proposed Sale	103.56	150,000	15,534,000	Nov 15 05:12 PM
Tureci Ozlem	Officer	Nov 12 '24	Proposed Sale	108.73	556,000	60,453,880	Nov 12 07:39 AM
ATHOS KG	10% Owner	Oct 16 '24	Proposed Sale	117.74	8,036	946,154	Oct 16 05:03 PM
ATHOS KG	10% Owner	Oct 14 '24	Proposed Sale	120.83	25,424	3,071,964	Oct 15 08:41 AM
ATHOS KG	10% Owner	Oct 11 '24	Proposed Sale	120.13	40,000	4,805,228	Oct 11 04:15 PM
ATHOS KG	10% Owner	Oct 10 '24	Proposed Sale	117.47	20,000	2,349,436	Oct 10 04:13 PM
ATHOS KG	10% Owner	Oct 09 '24	Proposed Sale	119.06	6,000	714,361	Oct 09 04:02 PM
ATHOS KG	10% Owner	Oct 08 '24	Proposed Sale	122.01	15,000	1,830,100	Oct 08 04:24 PM
ATHOS KG	10% Owner	Oct 04 '24	Proposed Sale	122.80	14,756	1,812,078	Oct 04 04:17 PM
ATHOS KG	10% Owner	Oct 03 '24	Proposed Sale	119.27	50,000	5,963,585	Oct 03 05:14 PM
ATHOS KG	10% Owner	Oct 02 '24	Proposed Sale	119.04	65,200	7,761,193	Oct 02 06:18 PM
ATHOS KG	10% Owner	Oct 01 '24	Proposed Sale	119.24	72,086	8,595,657	Oct 01 04:18 PM
ATHOS KG	10% Owner	Sep 30 '24	Proposed Sale	118.22	76,114	8,998,197	Sep 30 04:52 PM
ATHOS KG	10% Owner	Sep 27 '24	Proposed Sale	117.64	37,204	4,376,679	Sep 27 05:12 PM
ATHOS KG	10% Owner	Sep 25 '24	Proposed Sale	118.47	37,943	4,495,107	Sep 25 07:14 PM
ATHOS KG	10% Owner	Sep 18 '24	Proposed Sale	124.71	55,605	6,934,500	Sep 18 07:28 PM
ATHOS KG	10% Owner	Sep 17 '24	Proposed Sale	124.49	30,162	3,754,792	Sep 17 04:14 PM
ATHOS KG	10% Owner	Sep 16 '24	Proposed Sale	123.40	500,000	61,700,000	Sep 16 05:35 PM
ATHOS KG	10% Owner	Sep 16 '24	Proposed Sale	126.02	90,000	11,341,611	Sep 16 04:12 PM
ATHOS KG	10% Owner	Sep 13 '24	Proposed Sale	115.02	170,000	19,552,584	Sep 13 04:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNTX

BioNTech SE ADR

Upgrade your FINVIZ experience